Which Doctors Prescribe Peptides and What to Ask at Your First Visit

You've spent 20 minutes explaining what you want to a provider who's already decided you're being "influenced by the internet," and you're done. The good news: there are entire categories of practitioners who not only prescribe peptides like GHK-Cu, BPC-157, and CJC-1295 but build their practices around them. This article gives you the exact provider types, what each one costs in 2025, the questions that separate a serious clinician from a prescription mill, and a step-by-step route from your first search to your first injection.

Key Takeaways

• Any MD, DO, NP, or PA with full prescribing authority can legally prescribe compounded peptides, but the providers who actually do it well fall into three lanes: telehealth platforms ($149–$350 initial consult), functional/integrative MDs ($250–$500), and dedicated regenerative clinics ($300–$600+).
• Expect to spend $200–$600 on labs before your first protocol starts. Insurance almost never covers peptides, but some telehealth consults are reimbursable through out-of-network benefits.
• As of early 2026, roughly 14 of the 19 previously restricted peptides (including GHK-Cu, CJC-1295, and Ipamorelin) have been restored to Category 1 compounding status. BPC-157's compounding status is genuinely murky right now. At least one clinic source (Taylor Medical Group) reports that BPC-157 was restored to legal compounding status in February 2026, while a compounding pharmacy source (Massey Drugs) states it remains Category 2 under the FDA's interim 503A Bulks List, meaning 503A pharmacies still cannot compound it. Bottom line: confirm BPC-157's current status directly with your prescriber and pharmacy before assuming you can get it.
• A good provider orders labs before writing a protocol, schedules a follow-up within 30–60 days, and adjusts dosing based on your bloodwork and response. If someone skips all three, leave.
• The fastest path from "interested" to "injecting" is typically 10–21 days through telehealth, versus 3–6 weeks through an in-person clinic.

---

Why Your Regular Doctor Won't Prescribe Peptides (and Who Will)

Your internist didn't learn about GHK-Cu in medical school. Neither did your OB-GYN, your dermatologist, or honestly most endocrinologists. Peptide therapy sits outside the standard medical curriculum, which means the average primary care provider has zero framework for prescribing it, monitoring it, or even having an informed conversation about it. That's not malice. It's a training gap. But it means the appointment where you bring up BPC-157 and get a blank stare (or a patronizing redirect to "just use retinol") is predictable, not personal.

The providers who actually prescribe peptides and know what they're doing cluster in three lanes:

Telehealth peptide platforms. These are virtual practices built specifically around peptide therapy, hormone optimization, or both. You book online, do a video consult, get labs ordered to a local draw site, and receive your peptides shipped from a compounding pharmacy. The whole model is designed for women who know what they want and don't need to be convinced that wanting to look better is a valid medical goal. Practices like Revive Infusions & Wellness structure their entire telehealth model around this, with many consults reimbursable through out-of-network insurance benefits.

Functional and integrative MDs. These are physicians (MD or DO) who've moved beyond conventional practice into optimization medicine. They tend to run more comprehensive lab panels, spend longer on initial consults (45–90 minutes is common), and treat peptides as one tool in a larger protocol that might also include HRT, IV therapy, or targeted supplementation. The tradeoff: longer wait times, higher consult fees, and sometimes a philosophical deep-dive you didn't ask for.

Regenerative medicine clinics. Dedicated brick-and-mortar practices like Taylor Medical Group in Atlanta or Keystone Medical Wellness in Arizona that offer peptide therapy alongside aesthetics, PRP, and other regenerative treatments. These clinics typically have the broadest peptide menus (GHK-Cu, CJC-1295/Ipamorelin, BPC-157, PT-141, GLOW blends) and in-house injection training. You'll pay more, but you get hands-on oversight and often same-day starts after labs clear.

The point: the provider who prescribes your peptides doesn't need a specific specialty board certification in "peptide medicine" (that doesn't exist). They need prescribing authority, clinical experience with these compounds, and a protocol that includes labs and follow-up. That's the filter.

---

Telehealth vs. Functional MD vs. Regenerative Clinic: How Each Model Works

Choosing your provider lane is less about "which is best" and more about which model matches your schedule, your budget, and how much hand-holding you want. Here's how they actually differ in practice:

Telehealth is the fastest lane. You can typically go from booking to holding a vial in under three weeks. The consult is efficient, sometimes almost transactional, which is a feature if you've already done your research and just need someone with prescribing authority to review your labs and write the script. The limitation: you're on your own for reconstitution and injection technique (though most platforms provide detailed guides).

Functional MDs go deeper. Expect a full health history intake, sometimes a 90-minute first visit, and a lab panel that goes well beyond basic metabolic markers. They'll often check IGF-1, inflammatory markers, thyroid, sex hormones, and fasting insulin before building your protocol. If you're stacking peptides with HRT or addressing multiple goals at once (skin, body composition, energy), this is the lane where you get the most integrated plan. The cost reflects that.

Regenerative clinics give you the in-person experience. Someone physically shows you how to reconstitute, how to inject subcutaneously, where to rotate sites. If the idea of your first self-injection feels daunting, this matters. These clinics also tend to offer combination protocols (like the GLOW blend of GHK-Cu + BPC-157 + TB-500) that you might not find on a telehealth menu.

---

What Peptide Prescriptions Actually Cost in 2025

Nobody talks about this clearly enough, so here it is: peptide therapy is an out-of-pocket expense for most women. Insurance doesn't cover compounded peptides. It generally doesn't cover the consult either, unless your provider bills it as a general wellness visit or you have out-of-network benefits that apply. A few telehealth platforms specifically note that consults may be reimbursable through out-of-network benefits, so it's worth submitting the claim, but don't build your budget around getting that money back.

Here's what the real numbers look like in 2025:

A few things to note. GHK-Cu from a compounding pharmacy typically runs $120–$200 per 30-day cycle. CJC-1295/Ipamorelin combos tend to be $150–$250/month. Combination blends (like the GLOW blend) can run $200–$350/month. These prices vary by pharmacy and by how many milligrams per vial you're getting, not by which provider prescribes it.

The biggest cost variable isn't the peptide itself. It's the consult model. If you're doing quarterly telehealth check-ins at $100 each versus monthly in-person visits at $250 each, that difference compounds fast over a 6-month protocol. Pick the oversight level you actually need, not the one that feels most "medical."

---

The 2025 FDA Reclassification: Which Peptides Are Legal to Compound Right Now

Here's the regulatory picture as of mid-2025, stripped of the noise.

The FDA maintains what's called the Bulks Drug Substances list, which determines which compounds licensed compounding pharmacies can legally prepare. In recent years, the agency placed 19 peptides into Category 2 of the interim 503A Bulks List, effectively restricting compounding pharmacies from preparing them. This created a period where peptides that had been routinely prescribed by physicians were suddenly unavailable through legal pharmacy channels.

Then, in early 2026, HHS confirmed that approximately 14 of those 19 peptides would be restored to Category 1 status, meaning licensed 503A and 503B compounding pharmacies can once again prepare them under a valid physician prescription. Like most research peptides, injectable GHK-Cu isn't FDA-approved as a standalone drug, which is exactly why the interesting real-world evidence lives in what women are actually reporting and what peptide-literate providers are seeing in practice.

What this means for specific peptides right now:

• GHK-Cu: Category 1. Legally compoundable. Widely available through compounding pharmacies with a prescription.
• CJC-1295: Category 1 (restored). Available again through compounding pharmacies.
• Ipamorelin: Category 1 (restored). Commonly prescribed alongside CJC-1295.
• BPC-157: This is the notable exception. BPC-157 remains in Category 2 under the 503A framework, which means standard compounding pharmacies (503A) cannot currently compound it. Some 503B outsourcing facilities may have different access, and the regulatory landscape here is actively shifting. If BPC-157 is your primary goal, ask your provider directly about current sourcing options.
• Thymosin Alpha-1, Selank, Semax: Restored to Category 1.
• PT-141 (Bremelanotide): Actually FDA-approved as Vyleesi, so it's available through standard prescription channels.

The bottom line: most of the peptides women are interested in for skin quality, recovery, and body composition are legally prescribable again. Your provider's compounding pharmacy should be able to fill them. BPC-157 is the one to ask specifically about.

---

Exactly What to Ask at Your First Peptide Appointment

Your first consult is a two-way evaluation. You're not just being assessed; you're assessing. Here are the questions that separate a provider who knows what they're doing from one who's winging it:

About their practice:

1. "How long have you been prescribing peptide therapy, and roughly how many patients are on peptide protocols in your practice right now?" You want experience measured in years and patients, not enthusiasm.

1. "Which compounding pharmacy do you work with, and is it a licensed 503A or 503B facility?" This tells you whether they have an established pharmacy relationship or are figuring it out as they go.

1. "What's your follow-up protocol? When do I come back, and what triggers a dose adjustment?" A good answer is specific: "We recheck labs at 30 days, do a clinical assessment, and adjust based on your IGF-1 levels and how you're responding." A bad answer is "just let us know if anything feels off."

About your protocol:

1. "What labs do you need before we start, and what are you looking for?" Baseline labs typically include CBC, CMP, IGF-1, fasting insulin, thyroid panel, and sometimes inflammatory markers like CRP or ESR. If a provider prescribes without any labs, that's information.

1. "What's the planned duration of this protocol, and what does cycling look like?" Most peptide protocols run in 30–90 day cycles with planned breaks. Open-ended "just keep injecting" isn't a protocol.

1. "Are there any contraindications given my current medications or health history?" This is where a real provider earns their fee. Peptides that influence growth hormone secretion (like CJC-1295/Ipamorelin) require caution with active malignancies or a history of certain cancers. Growth hormone-releasing peptides interact with the hypothalamic-pituitary axis in ways that matter if you have pituitary conditions, diabetes, or are on certain medications. A provider who doesn't ask about your cancer history before prescribing a GH secretagogue is a provider to walk away from.

1. "What does injection training look like? Will someone walk me through reconstitution and injection technique?" Even if you're comfortable with needles, the first reconstitution of a lyophilized peptide vial with bacteriostatic water involves math (concentration per unit) and sterile technique that's worth getting right.

About expectations:

1. "Based on what you're prescribing, what's a realistic timeline for noticing results?" For GHK-Cu targeting skin quality, most women report visible changes between weeks 4 and 8. For CJC-1295/Ipamorelin targeting body composition, 8–12 weeks is more realistic. A provider who promises dramatic results in week one is selling you something.

Print this list. Bring it. Any provider worth their consult fee will respect that you showed up prepared.

---

Red Flags That Mean Walk Away

Not every provider who offers peptides is offering good peptide care. Here's what should make you close the tab or leave the office:

No labs, period. If a provider is willing to prescribe injectable peptides without ordering a single blood test, they're not practicing medicine. They're running a vending machine. Baseline labs aren't optional. They're how your provider knows your IGF-1 isn't already elevated, your liver function is normal, and your metabolic markers support the protocol they're writing.

No follow-up scheduled. You should leave your first appointment with a follow-up date on the calendar, typically 30–60 days out. "Call us if you need anything" is not a follow-up protocol.

Cookie-cutter dosing with no individualization. If every patient gets the exact same peptide at the exact same dose regardless of weight, age, labs, or goals, that's a red flag. Peptide protocols should be titrated. A 130-pound woman and a 190-pound woman don't run identical protocols.

No discussion of your health history or medications. Growth hormone secretagogues, in particular, have real interactions and contraindications. If nobody asks about your cancer history, your diabetes status, or what medications you're currently taking, the clinical oversight isn't there.

"Research use only" language on clinical products. If a provider is framing what they're prescribing you as "research use only" while clearly intending it for your therapeutic use, that's a legal and ethical problem. Legitimate peptide prescriptions come through licensed compounding pharmacies with a valid prescription.

No clear answer about their compounding pharmacy. A provider should be able to name the pharmacy they work with. If they can't, or if they get vague when you ask, that tells you something about how much thought they've put into the supply chain that ends with a needle in your skin.

---

What a Real GHK-Cu Protocol Looks Like Under Medical Supervision

Let's make this concrete. GHK-Cu (copper peptide, glycyl-L-histidyl-L-lysine) is one of the most popular peptides women run for skin quality, and it's a clean example of what supervised peptide care actually involves.

GHK-Cu is a naturally occurring tripeptide that declines significantly with age. By 60, your circulating levels are roughly 60% lower than at age 20. It plays a role in collagen synthesis, wound healing, anti-inflammatory signaling, and antioxidant enzyme production. The research on its mechanisms is strong. The clinical data on injectable protocols is still building, but what women and providers are reporting is genuinely exciting.

A typical supervised 30-day GHK-Cu cycle looks like this:

Your provider orders baseline labs (at minimum, CBC, CMP, and often IGF-1 and inflammatory markers). You have a consult where they review your goals, health history, and any contraindications. Then the protocol starts.

The Perfect B clinical protocol is a good reference point for what medical supervision looks like in practice: a structured 30-day cycle with defined injection frequency (typically daily subcutaneous injections), monitoring throughout, and a planned reassessment at the end of the cycle. Dosing is individualized based on your provider's assessment, not a one-size-fits-all number.

What women on GHK-Cu protocols consistently report:

• Weeks 1–2: Subtle improvements in skin hydration and "glow." Some women notice faster healing of minor cuts or blemishes.
• Weeks 3–4: More visible changes in skin texture and firmness. This is when the "what are you using?" questions tend to start.
• Weeks 6–8: The cumulative effect becomes hard to ignore. Skin looks plumper, fine lines soften, and overall tone evens out. Women who photograph their skin weekly often see the most dramatic difference in side-by-side comparisons at this point. For a detailed look at what longer protocols deliver, see what six months really looks like with consistent use.
• Post-cycle: Many providers recommend a break period before starting another cycle. The collagen remodeling that GHK-Cu initiates continues even after you stop injecting, so results don't vanish overnight.

The injection itself is subcutaneous (a short, thin needle into the fatty tissue of your abdomen or thigh), typically takes under 60 seconds, and most women describe it as less painful than a blood draw. The reconstitution process (mixing the lyophilized powder with bacteriostatic water) takes a couple of minutes once you've done it a few times.

This is what peptide therapy looks like when it's done right: labs, a plan, monitoring, and results you can see in the mirror.

---

Your Route Map: From First Search to First Injection

Here's the action plan, step by step:

Step 1: Decide your provider lane (Day 1). Telehealth if you want speed and convenience. Functional MD if you want a comprehensive health picture. Regenerative clinic if you want in-person oversight and injection training. All three are legitimate. Pick the one that matches your life.

Step 2: Book your consult (Days 1–3). Telehealth platforms often have availability within a week. In-person clinics may take 2–4 weeks. When booking, confirm that the provider prescribes the specific peptide you're interested in (not all providers carry all peptides).

Step 3: Get your labs drawn (Days 3–10). Most providers will send lab orders to Quest or Labcorp before your first consult so they can review results during your appointment. Some clinics do in-house draws. Don't skip this. It's the foundation of your protocol.

Step 4: Have your consult and confirm the plan (Days 7–14). Bring your question list. Confirm which peptide, what cycle length, what the follow-up schedule looks like, and which compounding pharmacy fills the prescription.

Step 5: Receive your peptides and start (Days 14–21). Shipping from compounding pharmacies typically takes 3–7 business days. Your vials arrive with reconstitution instructions. If you chose a clinic, you may pick up in-office and get your first injection supervised.

Step 6: Follow up on schedule (Day 30–60). Your provider reviews how you're responding, checks any repeat labs, and adjusts the protocol. This is where good care separates itself from a one-and-done prescription.

The whole process, from "I want to do this" to your first injection, is realistically 10–21 days through telehealth and 3–6 weeks through an in-person provider. That's it. The hardest part was finding a provider who takes you seriously, and now you know exactly where to look.

Not sure which peptide or protocol fits your goals? Build your personal plan and get a starting point matched to what you actually want.

---

Frequently Asked Questions

Can a nurse practitioner or PA prescribe peptides, or does it have to be an MD? Yes, NPs and PAs can prescribe peptides in most states. Nurse practitioners with full practice authority (currently 27 states plus DC grant this) can prescribe independently. In other states, NPs and PAs prescribe under a collaborative agreement with a physician. The credential matters less than the clinical experience. An NP who's managed 500 peptide patients is a better choice than an MD who's never written a peptide prescription.

Do I need blood work before starting peptide therapy? Yes, and you should insist on it even if a provider doesn't require it. Baseline labs (CBC, CMP, IGF-1, fasting insulin, thyroid panel) give your provider the information they need to prescribe safely and to measure whether the protocol is working. Expect to spend $200–$400 on labs through Quest or Labcorp.

Will my insurance cover peptide therapy or the consultation? Almost certainly not for the peptides themselves. Compounded peptides are not covered by insurance. However, some telehealth consultations may be reimbursable through out-of-network benefits, particularly if the visit is billed as a general wellness or hormone optimization consult. Submit the claim and see what happens, but budget as if it's fully out of pocket.

What's the difference between FDA-approved peptides and compounded peptides? A handful of peptides are FDA-approved drugs: semaglutide (Ozempic/Wegovy), tesamorelin (Egrifta), and bremelanotide/PT-141 (Vyleesi). These went through full clinical trials and have specific approved indications. Compounded peptides (GHK-Cu, CJC-1295, BPC-157) are prepared by licensed compounding pharmacies under a physician's prescription. They're legal to prescribe and use, but they haven't gone through the FDA drug approval process, which costs upward of $1 billion per compound. The cost of running full-scale FDA approval trials is a major barrier, but the lack of large-scale human safety and efficacy data also means the full risk profile isn't established the way it is for approved drugs. The FDA has even placed some peptides, including BPC-157, into Category 2 specifically citing safety concerns.

Can I get GHK-Cu or BPC-157 through telehealth? GHK-Cu, yes. Multiple telehealth platforms prescribe it and ship from compounding pharmacies. BPC-157 is more complicated right now because of its Category 2 status under the 503A framework. Ask your telehealth provider directly about current BPC-157 availability, as the regulatory situation is actively evolving.

How long does it take to see results from peptide therapy? It depends on the peptide and the goal. For GHK-Cu targeting skin quality, most women report noticeable improvements between weeks 4 and 8. For CJC-1295/Ipamorelin targeting body composition and recovery, 8–12 weeks is a more realistic timeline. Peptides are not instant. They work by supporting your body's own biological processes, which takes time.

What happened with the FDA peptide ban, and are peptides legal again in 2025? In short: the FDA placed 19 peptides into Category 2 (restricted) status, which temporarily prevented compounding pharmacies from preparing them. In early 2026, HHS restored approximately 14 of those peptides to Category 1 status, making them legally compoundable again under physician prescription. The notable exception is BPC-157, which remains Category 2 under 503A. The regulatory environment is still shifting, but the trend is toward restored access.

How often do I need follow-up appointments once I start a peptide protocol? Most providers schedule a follow-up at 30–60 days after starting a protocol, then move to quarterly check-ins once your protocol is stable. Follow-ups typically include a clinical assessment and sometimes repeat labs (particularly IGF-1 if you're on growth hormone secretagogues). Budget $75–$300 per follow-up depending on your provider type. These visits are where dose adjustments happen, so don't skip them.